patient focused drug development and the fda
Published 8 years ago • 171 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
7:32:56
fda rare disease day 2023: “intersections with rare diseases – a patient focused event”
-
3:41
fda cder regulatory science: patient-focused drug development
-
2:34:13
public webinar: patient-focused drug development draft guidance 3
-
1:59:38
public webinar: patient-focused drug development draft guidance 4
-
3:37
what is patient-focused drug development (pfdd)?
-
1:28
patient engagement at the fda
-
1:13:41
introduction to idiopathic inflammatory myopathies
-
4:06
chagas disease: a silent emergency
-
47:46
towards hope – new frontiers in neurodegenerative disease research (a temerty medicine talk)
-
1:07:59
data diy 2 - session 6: patient focused drug development
-
1:09:21
update on highly pathogenic avian influenza a(h5n1) virus for clinicians
-
56:13
a look at rare disease listening sessions with nord and the fda
-
3:57:57
public meeting: patient-focused drug development for vitiligo
-
3:00
how will rdca-dap® support patient-focused drug development?
-
2:30:29
public meeting: patient-focused drug development for hereditary angioedema (part 1 of 2)
-
1:32:12
public meeting: patient-focused drug development for chagas disease (part 1 of 4)
-
3:58:26
public meeting: patient-focused drug development for systemic sclerosis
-
2:07:05
public meeting on patient focused drug development for narcolepsy part 1
-
1:54:32
public meeting: patient-focused drug development for autism (part 1 of 2)
-
52:10
npf webinar: fda patient-focused drug development meeting prep
-
2:43:12
public meeting on patient focused drug development for sickle cell disease part 1
-
58:09
patient focused drug development - how rdca-dap can help